Global Human Insulin Market 2018-2024

  • Report Code : INF497542
  • Published On: Aug, 2020
  • Category : Pharmaceuticals
  • Pages : 77
  • Global Human Insulin Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023

    Overview: Insulin is a peptide hormone that helps in controlling the absorption of fat and carbohydrate in the body. The human insulin market is anticipated to grow at a robust CAGR during the forecast period due to a high incidence rate of diabetes, globally.

    The growth in the prevalence rate of diabetes, changes in lifestyles, rising number of obese patients, and increasing geriatric population are the major factors driving the market growth. However, the high cost for the development and production of insulin, manufacturing complexities, and stringent regulatory scenario for the approval of derived products are hampering the growth of the market. The development of pipeline insulin products and expiry of key patents are providing an opportunity for the manufacturers of human insulin.

    Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three segments – top insulin brands, product types, and regions.

    Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the global human insulin market, followed by Europe, Asia Pacific, and Rest of the World. Nearly half of the market is occupied by North America, with the US being the major contributor to the market growth.

    Product Analysis: Based on types, the market is segmented into modern human insulin and traditional human insulin. Modern human insulin includes rapid-acting insulin analogs, premixed analogue insulins, and long-acting insulin. Traditional human insulin includes regular human insulin, NPH human insulin, and pre-mixed insulin. Novo Nordisk holds 45.0% share of the total modern insulin market.

    Top Insulin Brands: Lantus is the major insulin drug in the market. Due to the loss of patents, the drug has got competition in the form of biosimilar by name Basaglar from Eli Lilly. After the loss of share for its biosimilar counterpart, the drug lost its value for its follow-up drug Toujeo. Since the launch of Toujeo in April 2015, the company has been switching over as many patients as possible to the newer drug to fill the sales gap caused by the reduced revenue of Lantus.

    Key Players: Novo Nordisk, Sanofi A/S, Eli Lilly & Company, and Astra Zeneca PLC are the key players in the market. The other prominent players in the market include Biocon, Julphar, Wockhardt, GSK, Oramed, and SemBioSys Genetics.

    Competitive Analysis: Regardless of the size of the total market, it is chiefly dominated by Novo Nordisk, Sanofi, and Eli Lilly. These firms function globally either independently or through subsidiaries and distributors. The insulin products of Novo Nordisk are sold in 111 countries along with 101 countries for Sanofi’s insulin products and 94 countries for Eli Lilly’s insulin products. Especially in higher income countries of Western Europe, nearly 55% of insulin products are sold by these major manufacturers. Moreover, in 2012, they occupied 88.7% of share in the global insulin market. However, there are many small companies involved in the production and sales of insulin products. Other major companies in the market are Wockhardt, Biocon, Julphar, Oramed, GSK, and SemBioSys Genetics Inc.

    Benefits: The report provides complete details about the usage and adoption rate of human insulin in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

    Key Stakeholders:

     

  • With tables and figures helping analyze worldwide Global Human Insulin market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Industry Outlook 8

    1.1 Industry Overview 8

    1.2 Total Addressable Market 8

    1.3 Industry Trends 10


    2 Report Outline 11

    2.1 Report Scope 11

    2.2 Report Summary 11

    2.3 Research Methodology 12

    2.4 Report Assumptions 12


    3 Market Snapshot 13

    3.1 Market Definition – Infoholic Research 13

    3.2 Segmented Addressable Market (SAM) 13

    3.2.1 Trends of Human Insulin market 14

    3.3 Related Markets 15

    3.3.1 Oncology (Cancer) Drugs 15
    3.3.2 Active pharmaceutical ingredients (APIs) 16
    3.3.3 Over the counter drugs (OTC) 16
    3.3.4 Diabetes Drugs 17

    4 Market Outline 18

    4.1 Pipeline products 18

    4.2 Market Segmentation 18

    4.3 Porter 5(Five) Forces 19

    4.4 PEST Analysis 20


    5 Market Characteristics 21

    5.1 Market Dynamics 22

    5.1.1 Drivers 22
    5.1.1.1 Increasing Aging Population 22
    5.1.1.2 Increasing People Suffering with Diabetes 24
    5.1.2 Opportunities 24
    5.1.2.1 Increase healthcare spending 24
    5.1.2.2 Patent Expiry for Blockbuster Drugs 25
    5.1.3 Restraints 25
    5.1.3.1 Complex regulatory process 25
    5.1.3.2 High cost of insulin 25
    5.1.4 DRO – Impact Analysis 27
    5.1.5 Key Stakeholders 28

    6 Insulin Types: Market Size and Analysis 29

    6.1 Overview 29

    6.2 Lantus 29

    6.3 Humulin 29

    6.4 Levemir 30

    6.5 Humalog 30

    6.6 NovoLog/NovoRapid 30

    6.7 Tresiba 31
    6.8 Basaglar/ Abasaglar 31
    6.9 Toujeo 31
    6.10 Apidra 32
    Company: Sanofi 32

    7 Types: Market Size and Analysis 33

    7.1 Overview 33

    7.2 Modern Insulin 34

    7.2.1 Rapid Acting Insulin Analogs 34
    7.2.2 Premixed analogue insulins 34
    7.2.3 Long-acting insulin 34

    7.3 Traditional Human Insulin 35

    7.3.1 Regular Human Insulin 35
    7.3.2 NPH Human Insulin 36
    7.3.3 Pre-Mixed Insulin 36

    8 Regions: Market Size and Analysis 37

    8.1 Overview 37

    8.2 North America 39

    8.2.1 Overview 39
    8.2.2 United States 40
    8.2.3 Canada 41

    8.3 Europe 41

    8.3.1 Overview 41
    8.3.2 United Kingdom 42
    8.3.3 Germany 42

    8.4 APAC 43

    8.4.1 Overview 43
    8.4.2 India 43
    8.4.3 China 44
    8.4.4 Japan 44

    8.5 Rest of the World 45

    8.5.1 Overview 45
    8.5.2 Middle East and Africa 46
    8.5.3 Brazil 46

    9 Competitive Landscape 47

    10 Vendor Profiles 50

    10.1 Novo Nordisk A/S 50

    10.1.1 Overview 50
    10.1.2 Geographic Revenue 52
    10.1.3 Business Focus 52
    10.1.4 SWOT Analysis 53
    10.1.5 Business Strategy 53

    10.2 Sanofi 54

    10.2.1 Overview 54
    10.2.2 Geographic Revenue 57
    10.2.3 Business Focus 57
    10.2.4 SWOT Analysis 58
    10.2.5 Business Strategy 58

    10.3 Eli Lilly & Company Ltd 59

    10.3.1 Overview 59
    10.3.2 Business Focus 62
    10.3.3 SWOT Analysis 63
    10.3.4 Business Strategies 63

    10.4 Astra Zenca PLC. 64

    10.4.1 Overview 64
    10.4.2 Geographic Presence 68
    10.4.3 Business Focus 68
    10.4.4 SWOT Analysis 69
    10.4.5 Business Strategy 69

    11 Companies to Watch For 70

    11.1 GlaxoSmithKline plc 70

    11.1.1 Overview 70

    11.2 Julphar Gulf Pharmaceutical Industries. 71

    11.2.1 Overview 71
    11.2.2 Highlights 72

    11.3 Biocon Ltd 72

    11.3.1 Overview 72

    11.4 Wockhardt 74

    11.4.1 Overview 74
    11.4.2 Highlights 74

    11.5 Oramed 74

    11.5.1 Overview 74
    11.5.2 Highlights 75

    11.6 SemBioSys Genetics Inc. 75

    11.6.1 Overview 75
    Annexure 76
    Abbreviations 76
    Tables
    TABLE 1 HUMAN INSULIN MARKET REVENUE BY TYPES, 2017–2024 ($MILLION) 33
    TABLE 2 HUMAN INSULIN MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 39
    TABLE 3 NOVO NORDISK A/S: PRODUCT OFFERINGS 50
    TABLE 4 NOVO NORDISK A/S: RECENT DEVELOPMENTS 50
    TABLE 5 SANOFI: OFFERINGS 54
    TABLE 6 SANOFI: RECENT DEVELOPMENTS 55
    TABLE 7 ELI LILLY & COMPANY LTD.: PRODUCT OFFERINGS 59
    TABLE 8 ELI LILLY & COMPANY LTD.: RECENT DEVELOPMENTS 59
    TABLE 9 ASTRA ZENCA PLC: OFFERINGS 64
    TABLE 10 ASTRA ZENCA PLC: RECENT DEVELOPMENTS 64
    TABLE 11 GLAXOSMITHKLINE PLC.: OVERVIEW 70
    TABLE 12 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 70
    TABLE 13 JULPHAR GULF PHARMACEUTICAL INDUSTRIES: OVERVIEW 72
    TABLE 14 BIOCON LTD: OVERVIEW 73
    TABLE 15 BIOCON LTD: RECENT DEVELOPMENTS 73
    TABLE 16 SOLUBLE SYSTEMS LLC: OVERVIEW 74
    TABLE 17 ORAMED: OVERVIEW 75
    TABLE 18 SEMBIOSYS GENETICS INC.: RECENT DEVELOPMENTS 75

    Charts
    CHART 1 RESEARCH METHODOLOGY OF GLOBAL HUMAN INSULIN MARKET 12
    CHART 2 PERCENTAGE OF DIABETICS UNDIAGNOSED IN WORLD REGIONS IN 2017 13
    CHART 3 GLOBAL HUMAN INSULIN MARKET REVENUE, 2017-2024 ($MILLION) 15
    CHART 4 SEGMENTATION OF GLOBAL HUMAN INSULIN MARKET 18
    CHART 5 PORTER 5 FORCES OF HUMAN INSULIN MARKET 19
    CHART 6 PEST ANALYSIS OF HUMAN INSULIN MARKET 20
    CHART 7 MARKET DYNAMICS – DRO ANALYSIS 22
    CHART 8 AGEING DEMOGRAPHIC GROWTH 23
    CHART 9 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960-2060 (%) 24
    CHART 10 INFLATION IN THE INSULIN PRICES PER VIAL ($) 26
    CHART 11 DRO – IMPACT ANALYSIS OF GLOBAL HUMAN INSULIN MARKET 27
    CHART 12 KEY STAKEHOLDERS 28
    CHART 13 HUMAN INSULIN MARKET BY TYPES SEGMENTATION, 2017 ($MILLION) 33
    CHART 14 MODERN HUMAN INSULIN MARKET BY TYPES SEGMENTATION, 2017 ($MILLION) 34
    CHART 15 HUMAN INSULIN MARKET BY TYPES SEGMENTATION, 2017 ($MILLION) 36
    CHART 16 NUMBER OF DIABETICS WORLDWIDE IN 2017, BY REGION (IN MILLIONS) 38
    CHART 17 HUMAN INSULIN MARKET BY REGIONAL SEGMENTATION, 2017 VS 2024 (%) 38
    CHART 18 HUMAN INSULIN MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 39
    CHART 19 HUMAN INSULIN MARKET REVENUE IN THE EUROPE REGION, 2017–2023 ($MILLION) 41
    CHART 20 HUMAN INSULIN MARKET REVENUE IN THE APAC REGION, 2017–2023 ($MILLION) 44
    CHART 21 HUMAN INSULIN MARKET REVENUE IN REST OF THE WORLD, 2017–2023 ($MILLION) 45
    CHART 22 MODERN INSULIN MARKET SHARE 2017 (%SHARE) 48
    CHART 23 NOVO NORDISK A/S: OVERVIEW SNAPSHOT 51
    CHART 24 NOVO NORDISK A/S: SEGMENTATION 51
    CHART 25 NOVO NORDISK A/S: GEOGRAPHIC REVENUE 52
    CHART 26 NOVO NORDISK A/S: SWOT ANALYSIS 53
    CHART 27 SANOFI SA: OVERVIEW SNAPSHOT 55
    CHART 28 SANOFI SA: SEGMENTATION 56
    CHART 29 SANOFI SA: GEOGRAPHIC REVENUE 57
    CHART 30 SANOFI SA: SWOT ANALYSIS 58
    CHART 31 ELI LILLY & COMPANY LTD.: OVERVIEW SNAPSHOT 60
    CHART 32 ELI LILLY & COMPANY LTD.: OVERVIEW SNAPSHOT 61
    CHART 33 ELI LILLY & COMPANY LTD.: GEOGRAPHIC REVENUE 62
    CHART 34 ELI LILLY & COMPANY LTD.: SWOT ANALYSIS 63
    CHART 35 ASTRA ZENCA PLC: OVERVIEW SNAPSHOT 65
    CHART 36 ASTRA ZENCA PLC: BUSINESS UNITS 67
    CHART 37 ASTRA ZENCA PLC: GEOGRAPHIC PRESENCE 68
    CHART 38 ASTRA ZENCA PLC: SWOT ANALYSIS 69

     

  • The Global Human Insulin Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
      By Regions:
        By Type:
          By Application:
          Licensing options
          2750
          USD

          Need assistance ?

          Related reports

          Research objectives

          Where will all these developments take the industry in the long

          To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

          What are the future opportunities in the market?

          To understand the structure of Market by identifying its various subsegments.

          What are the major driving forces expected to impact the development of the market market across different regions?

          To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

          Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

          To project the consumption of market submarkets, with respect to key regions.

          Who are the major driving forces expected to decide the fate of the industry worldwide.

          To strategically profile the key players and comprehensively analyze their growth strategies.

          What are the key barriers and threats believed to hinder the development of the industry?

          To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

          Who are the prominent market players making a mark in the market with their winning strategies?

          To share detailed information about the key factors influencing the growth of the market

          What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

          Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

          Our Clients